CAS: 103878-83-7 - N-(2-Aminoethyl)-5-chlor-2-pyridincarboxamid-hydrochlorid
Fórmula:C8H11Cl2N3O
InChI:InChI=1S/C8H10ClN3O.ClH/c9-6-1-2-7(12-5-6)8(13)11-4-3-10;/h1-2,5H,3-4,10H2,(H,11,13);1H
Clave InChI:InChIKey=JMFKTFLARGGXCC-UHFFFAOYSA-N
SMILES:Cl.O=C(NCCN)C1=NC=C(Cl)C=C1
- Sinónimos:
- 2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro-, hydrochloride (1:1)
- 2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro-, monohydrochloride
- Lazabemide hydrochloride
- N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrochloride
- N-(2-aminoethyl)-5-chloropyridine-2-carboxamide hydrochloride (1:1)
- Ro 19-6327
- Ro 19-6327/001
- Tempium
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Lazabemide hydrochloride REF: IN-DA008599CAS: 103878-83-7 | 98% | A consultar | Mar 10 Dic 24 | |
Lazabemide hydrochloride REF: TM-T5678CAS: 103878-83-7 | 98.65% | 55,00 €~275,00 € | Mar 17 Dic 24 | |
Lazabemide hydrochloride REF: 3D-DEA87883CAS: 103878-83-7 | Min. 95% | A consultar | Mar 21 Ene 25 |
Lazabemide hydrochloride
CAS:103878-83-7
Fórmula:
C8H11Cl2N3O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
236.0984
Ref: IN-DA008599
10mg | 145,00 € | ||
50mg | 495,00 € | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Lazabemide hydrochloride
CAS:103878-83-7
Lazabemide hydrochloride (N-(2-Aminoethyl)-5-chlor-2-pyridincarbox) is a reversible and selective mao-b inhibitor(Ki:7.9nM).
Fórmula:
C8H11Cl2N3O
Pureza:
98.65%
Forma y color:
Solid
Peso molecular:
236.098
Ref: TM-T5678
5mg | 55,00 € | ||
10mg | 70,00 € | ||
25mg | 113,00 € | ||
50mg | 168,00 € | ||
100mg | 275,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
Lazabemide hydrochloride
CAS:103878-83-7
Lazabemide hydrochloride is a drug that inhibits the action of monoamine oxidase (MAO) in the …
Fórmula:
C8H10ClN3O·HCl
Pureza:
Min. 95%
Peso molecular:
236.1 g/mol
Ref: 3D-DEA87883
50mg | 264,00 € | ||
500mg | 1.054,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025